Robert W Dubois

Summary

Publications

  1. ncbi Looking at CER from the pharmaceutical industry perspective
    Robert W Dubois
    NationalPharmaceutical Council, Washington, DC 20006, USA
    J Manag Care Pharm 18:S9-12. 2012
  2. ncbi Setting priorities for comparative effectiveness research: from assessing public health benefits to being open with the public
    Robert W Dubois
    National Pharmaceutical Council, Washington, DC, USA
    Health Aff (Millwood) 30:2235-42. 2011

Detail Information

Publications2

  1. ncbi Looking at CER from the pharmaceutical industry perspective
    Robert W Dubois
    NationalPharmaceutical Council, Washington, DC 20006, USA
    J Manag Care Pharm 18:S9-12. 2012
    ..But the growth of CER also brings an array of questions and decisions for purchasers and policy makers that will not be easy to answer and which require significant dialogue to fully understand and address...
  2. ncbi Setting priorities for comparative effectiveness research: from assessing public health benefits to being open with the public
    Robert W Dubois
    National Pharmaceutical Council, Washington, DC, USA
    Health Aff (Millwood) 30:2235-42. 2011
    ..We also recommend that during the priority-setting process, there should be transparent conversations among those who make decisions about the priorities and the public...